2009 Version of the Chompret Criteria for Li Fraumeni Syndrome

Journal of Clinical Oncology

Volumn 27, Issue 26, 2009, Pages

  Tinat, Julie ^a,b   Bougeard, Gaelle ^a,b   Baert Desurmont, Stéphanie ^a,b   Vasseur, Stéphanie ^a,b   Martin, Cosette ^a,b   Bouvignies, Emilie ^a,b   Caron, Olivier ^c   BrigitteBressac De Paillerets, Brigitte ^c   Berthet, Pascaline ^d   Dugast, Catherine ^e   Bonaïti Pellié, Catherine ^f   Stoppa Lyonnet, Dominique ^g,h   Frébourg, Thierry ^a,b  

^a UNIVERSITÉ DE ROUEN   (France)

^b ROUEN UNIVERSITY HOSPITAL   (France)

^c INSTITUT GUSTAVE ROUSSY   (France)

^d CENTRE FRANÇOIS BACLESSE   (France)

^e RENNES UNIVERSITY HOSPITAL   (France)

^f INSERM   (France)

^g INSTITUT CURIE   (France)

^h UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA2 PROTEIN; PROTEIN P53;

ADRENAL CORTEX CARCINOMA; BRAIN TUMOR; BREAST CANCER; CANCER DIAGNOSIS; CHOMPRET CRITERIA; CHOROID PLEXUS TUMOR; CRITERION VARIABLE; EXON; FAMILIAL CANCER; LETTER; LEUKEMIA; LUNG ALVEOLUS CELL CARCINOMA; MULTIPLEX POLYMERASE CHAIN REACTION; MUTATION; OSTEOSARCOMA; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SOFT TISSUE SARCOMA; GENETICS; HUMAN; NOTE;

HUMANS; LI-FRAUMENI SYNDROME; MUTATION; SENSITIVITY AND SPECIFICITY; TUMOR SUPPRESSOR PROTEIN P53;

EID: 70349320378     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2009.22.7967     Document Type: Letter

References (3)

1. Gonzalez KD, Noltner KA, Buzin CH, et al: Beyond Li Fraumeni syndrome: Clinical characteristics of families with p53 germline mutations. J Clin Oncol 27:1250-1256, 2009
2. Chompret A, Abel A, Stoppa-Lyonnet D, et al: Sensitivity and predictive value of criteria for p53 germline mutation screening. J Med Genet 38:43-47, 2001
3. Bougeard G, Sesboüé R, Baert-Desurmont S, et al: Molecular basis of the Li-Fraumeni syndrome: An update from the French LFS families. J Med Genet 45:535-538, 2008